Logotipo del repositorio
 

Impact of sensor-augmented pump therapy with predictive low-glucose management on hypoglycemia and glycemic control in patients with type 1 diabetes mellitus : 1-year follow-up

Vista sencilla de ítem
dc.contributor.authorGómez, Ana María
dc.contributor.authorHenao, Diana C.
dc.contributor.authorLeguizamón, Guillermo
dc.contributor.authorRondón, Martín A.
dc.contributor.authorMuñoz, Oscar
dc.contributor.authorGarcía Jaramillo, María A.
dc.contributor.authorLeón Vargas, Fabián
dc.contributor.authorTaboada, Lucía B.
dc.contributor.corporatenamePontificia Universidad Javeriana. Facultad de Medicina. Departamento de Epidemiología Clínica y Bioestadística
dc.date.accessioned2020-05-08T12:02:22Z
dc.date.available2020-05-08T12:02:22Z
dc.date.created2019-07-10
dc.description.abstractenglishAIMS: To describe real-life experience with sensor-augmented pump therapy with predictive low-glucose management (SAPT-PLGM), in terms of hypoglycemia and glycemic control after one year of follow-up in T1D patients with hypoglycemia as the main indication of therapy. METHODS: Retrospective cohort study under real life conditions. Baseline and one-year follow-up variables of glycemic control, hypoglycemia and glycemic variability were compared. RESULTS: Fifty patients were included, 31 on prior treatment with SAPT with low-glucose suspend (LGS) feature and 19 on multiple dose insulin injections (MDI). Mean HbA1c decreased in the MDI group (8.24%-7.08%; p = 0.0001). HbA1c change was not significant in the SAPT-LGS group. Area under the curve (AUC) below 70 mg/dl improved in both SAPT-LGS and MDI groups while AUC, %time and events below 54 mg/dl decreased in SAPT-LGS group. Glycemic variability improved in the MDI group. Less patients presented severe hypoglycemia with SAPT-PLGM in both groups, however the change was non-significant. CONCLUSIONS: Under real life conditions, SAPT-PLGM reduced metrics of hypoglycemia in patients previously treaded with MDI and SAPT-LGS without deteriorating glycemic control in SAPT-LGS patients, while improving it in patients treated with MDI.spa
dc.description.paginas2625-2631spa
dc.description.quartilescopusQ2spa
dc.description.tipoarticuloArtículo originalspa
dc.formatPDFspa
dc.format.mimetypeapplication/pdfspa
dc.format.soportePapel / Electrónicospa
dc.identifierhttps://eds-a-ebscohost-com.ezproxy.javeriana.edu.co/eds/detail/detail?vid=1&sid=3eb45100-1e58-438f-83f2-c9564389522e%40sessionmgr4007&bdata=Jmxhbmc9ZXMmc2l0ZT1lZHMtbGl2ZQ%3d%3d#AN=edselc.2-52.0-85068894227&db=edselcspa
dc.identifier.doihttps://doi.org/10.1016/j.dsx.2019.07.024spa
dc.identifier.issn18780334 / 18714021 (Electrónico)spa
dc.identifier.urihttp://hdl.handle.net/10554/49109
dc.rights.licenceAtribución-NoComercial 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.sourceDiabetes and Metabolic Syndrome: Clinical Research and Reviews; Vol. 13 Núm. 4 (2019)spa
dc.subject.keywordDiabetes mellitusspa
dc.subject.keywordGlycated hemoglobin Aspa
dc.subject.keywordHypoglycemiaspa
dc.subject.keywordInsulin infusion systemsspa
dc.subject.keywordSensor-augmented pump therapyspa
dc.subject.keywordType 1spa
dc.titleImpact of sensor-augmented pump therapy with predictive low-glucose management on hypoglycemia and glycemic control in patients with type 1 diabetes mellitus : 1-year follow-upspa
dc.typeinfo:eu-repo/semantics/article
dc.type.hasversionhttp://purl.org/coar/version/c_ab4af688f83e57aa
dc.type.localArtículo de revistaspa

Archivos

Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
Artículo Repositorio.pdf
Tamaño:
645.1 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
2.54 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos